logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Fiona Thistlethwaite

The University of Manchester
H指数:25
被引数:4,683

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework

英国肿瘤药物研发：过去25年的分析及对2026年临床试验监管框架重启的关注

British Journal of Cancer
IF6.8
2026-07-230
OA
Paulina Czajka-Francuz; Chris Twelves; James Spicer; Archana Munje; Laura Vidal; Ruth Plummer; Dinesh Mistry; Maksym Novikov; Jim Bush; Gopalakrishnan Srinivasan; Soma Das; Sharan Sandhu; Vikram Bohra; Chinmayee Joshi; Ken Morrison; Suvarna Chavan; Fiona Thistlethwaite; Andrew Walding; Glen Clack; Michael George; Debashis Sarker; Raghib Ali; Sarah P. Blagden; Thomas R. Jeffry Evans; Kamal S. Saini
Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer

靶向线粒体过氧还原蛋白3在癌症中的临床前表征和I期临床测试

Nature Communications
IF15.7
2026-07-140
OAAI
Victoria Gibson; Joanna Dzialo; Terri Messier; Aleksandra Bzura; Charlotte Poile; Jan Rogel; Jens C. Hahne; Aida Habibovic; Stephanie Stead; Alexis Saaman; Kevin G. Blyth; Peter W. Szlosarek; Simon Lord; Fiona Thistlethwaite; Min Zhang; Apostolos Nakas; Peter Wells-Jordan; Kudzayi Kutywayo; Kelly J. Butnor; Nicholas. H. Heintz; George N. Naumov; Maurice Dungey; Julio Herrero Colomina; Burak Aktas; Sean Dulloo; James Spicer; Dean A. Fennell; Brian Cunniff
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial

西比萨他马贝和FAP-4-1BBL在微卫星稳定型结直肠癌中的研究：一项1b期临床试验

Nature Medicine
IF50
2026-04-200
OAAI
Ignacio Melero; Tamara Tanos; Emiliano Calvo Aller; Camilla Qvortrup; Marloes van Dongen; Iosune Baraibar; Seung-Hoon Beom; Fiona Thistlethwaite; Maria del Carmen Riesco; Maria Martinez Garcia; Victoria Woodcock; Tae Won Kim; Pablo Umana; Christine McIntyre; Lining Chen; Christian Heichinger; Heather Hinton; Tulun Saylan; Iakov I. Davydov; Ernesto Guarin; Axel Boehnke; Victor Moreno
Corrigendum to “T-cell engager toxicity in clinical phase trials; A systematic review and meta-analysis”. [Cancer Treat Rev. 139 (2025) 102991. doi: 10.1016/j.ctrv.2025.102991]

勘误：“T-cell engager toxicity in clinical phase trials; A systematic review and meta-analysis”。[Cancer Treat Rev. 139 (2025) 102991. doi: 10.1016/j.ctrv.2025.102991]

Cancer Treatment Reviews
IF10.5
2025-11-250
OAAI
Zoulikha M. Zaïr; Gemma Butterworth; Mariam Shalaby; Eduard Oštarijaš; Fiona Thistlethwaite
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors

晚期实体瘤患者AXL特异性抗体药物偶联物Enapotamab Vedotin的I/II期研究

Cancer Research Communications
IF0
2025-11-010
OA
Rohrberg, Kristoffer Staal; Lopez, Juanita S.; Milhem, Mohammed M.; Blank, Christian U.; Reijers, Irene; Thistlethwaite, Fiona; Plummer, Ruth; Piha-Paul, Sarina A.; Janne, Pasi A.; Shum, Elaine; Shaw, Heather M.; Debruyne, Philip R.; Lao, Cristopher; Baurain, Jean-Francois; Choe, Jennifer H.; Gort, Eelke; Zhao, Yujie; Jerusalem, Guy; Schoffski, Patrick; Chen, Andrew William; Cohen, Eric A.; Mankowski, Walter C.; Roshkovan, Leonid; Katz, Sharyn I.; Kontos, Despina; Brady, Lauren K.; Qutaish, Mohammed; Castro, Patricia Garrido; Pencheva, Nora; Bajaj, Gaurav; Fu, Yali; Windfeld, Kristian; Reiter, Panagiota; Jure-Kunkel, Maria; Higgs, Brandon W.; Amiri, Katayoun I.; Ahmadi, Tahamtan; Forssmann, Ulf; Ramalingam, Suresh S.; Vergote, Ignace
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma

I期ADP-A2AFP TCR T细胞疗法在晚期肝细胞癌或胃肝样腺癌患者中的临床试验

Journal of Hepatology
IF33
2025-08-120
PREAI
Tim Meyer; Richard S. Finn; Mitesh Borad; Amit Mahipal; Julien Edeline; Roch Houot; Petr F. Hausner; Antoine Hollebecque; Lipika Goyal; Matthew Frigault; Thomas R. Jeffry Evans; Kit Man Wong; Benjamin R. Tan; Emmanuel Mitry; Debashis Sarker; Lynn Feun; Bassel El-Rayes; Fiona Thistlethwaite; Ahmed Kaseb; Olatunji Alese
Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies

I期IMCnyeso研究，该研究是一种靶向NY-ESO-1表达性恶性病变的T细胞受体双特异性ImmTAC。

CELL REPORTS MEDICINE
IF10.6
2025-04-010
OAAI
Lopez, Juanita S.; Milhem, Mohammed; Butler, Marcus O.; Thistlethwaite, Fiona; Van Tine, Brian A.; D'Angelo, Sandra P.; Johnson, Melissa L.; Sato, Takami; Arkenau, Hendrik-Tobias; Edukulla, Ramakrishna; Wustner, Jason; Marshall, Shannon; Rodon, Jordi
Phase I safety and efficacy of brenetafusp, a PRAME x CD3 ImmTAC T cell engager, in platinum resistant ovarian cancer (PROC)

I期安全性及有效性研究：brenetafusp（一种PRAME x CD3 ImmTAC T细胞结合剂）在铂耐药卵巢癌（PROC）中的应用

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Friedman, C.; Williams, A. De Burgh; Lopez, J. S.; Ouali, K.; Middleton, M. R.; Thistlethwaite, F.; Hamid, O.; Izar, B.; Garcia, V. Moreno; Johnson, M. L.; Davar, D.; Martin-Liberal, J.; Roxburgh, P.; Moore, K. N.; Olson, D.; Rottey, S.; Kirk, P. B.; Yuan, Y.; Marshall, S.; Yeku, O.
Enhanced pharmacodynamic effects upon combination of cibisatamab and FAP-4-1BBL in 3L+mMSS CRC patients

cibisatamab与FAP-4-1BBL联合应用在3L+mMSS CRC患者中的增强药效学效应

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Melero, I.; Tanos, T.; Heichinger, C.; Davydov, I.; Boehnke, A.; Kumpesa, N.; Ooi, C.; Karanikas, V.; Cannarile, M.; Baraibar Argota, I.; Martinez Garcia, M.; Moreno Garcia, V.; Qvortrup, C.; Kim, T. W.; Beom, S-H.; Van Dongen, M. G.; Calvo, E.; Riesco Martinez, M. C.; Thistlethwaite, F.; Woodcock, V. K.
Maintenance durvalumab after fi rst-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study
ESMO OPEN
IF8.3
2024-07-010
OAAI
Fong, C.; Patel, B.; Peckitt, C.; Bourmpaki, E.; Satchwell, L.; Cromarty, S.; Kidd, S.; von Loga, K.; Uhlik, M.; Begum, R.; Rana, T.; Waddell, T.; Darby, S.; Bradshaw, A.; Roques, T.; Morgan, C.; Rees, C.; Herbertson, R.; Das, P.; Thompson, C.; Hewish, M.; Petty, R.; Thistlethwaite, F.; Rao, S.; Starling, N.; Chau, I.; Cunningham, D.

研究方向

暂未获取到该数据
N
Natalie Cook
H 指数:33论文数:285被引数:8,085
D
Donna M. Graham
H 指数:21论文数:156被引数:1,932
M
Matthew Krebs
H 指数:49论文数:319被引数:1.4万
L
Louise Carter
H 指数:20论文数:112被引数:3,376
J
James Spicer
H 指数:67论文数:566被引数:1.5万
M
Manon Pillai
H 指数:7论文数:43被引数:526
K
Kyrillus S. Shohdy
H 指数:15论文数:85被引数:748
J
Janelle Yorke
H 指数:41论文数:368被引数:5,892
S
S. Aruketty
H 指数:3论文数:17被引数:315
R
Ruth Plummer
H 指数:59论文数:604被引数:1.3万